S. Nitschmann

454 total citations
56 papers, 236 citations indexed

About

S. Nitschmann is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S. Nitschmann has authored 56 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 13 papers in Cardiology and Cardiovascular Medicine and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S. Nitschmann's work include SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (4 papers) and Lipoproteins and Cardiovascular Health (4 papers). S. Nitschmann is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (4 papers) and Lipoproteins and Cardiovascular Health (4 papers). S. Nitschmann collaborates with scholars based in Germany, Switzerland and Austria. S. Nitschmann's co-authors include Marc Thill, Roland Klingenberg, Michael Hallek, Max Augustin, H.-C. Diener, Lars Christian Rump, Andreas M. Kaufmann, Rieke Alten, Guido Gerken and Hans Hauner and has published in prestigious journals such as Der Internist, PubMed and Die Innere Medizin.

In The Last Decade

S. Nitschmann

41 papers receiving 232 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Nitschmann Germany	5	92	83	40	37	33	56	236
Monica G. Valero United States	11	64 0.7×	100 1.2×	35 0.9×	30 0.8×	106 3.2×	29	265
Aasems Jacob United States	8	61 0.7×	37 0.4×	15 0.4×	79 2.1×	32 1.0×	40	230
Kwang Hyun Yoon South Korea	8	126 1.4×	105 1.3×	17 0.4×	40 1.1×	95 2.9×	18	284
Irena Kuzmickienė Lithuania	9	120 1.3×	95 1.1×	15 0.4×	97 2.6×	108 3.3×	20	356
Sara Koo United Kingdom	9	150 1.6×	28 0.3×	37 0.9×	73 2.0×	76 2.3×	20	290
Karan Seegobin United States	10	81 0.9×	42 0.5×	9 0.2×	107 2.9×	31 0.9×	56	281
Qilong Yi United States	11	85 0.9×	78 0.9×	43 1.1×	77 2.1×	91 2.8×	17	421
Vanessa Pachón Spain	8	173 1.9×	36 0.4×	14 0.3×	24 0.6×	19 0.6×	19	242
M. Kiechle-Bahat Germany	6	48 0.5×	71 0.9×	47 1.2×	116 3.1×	78 2.4×	11	347
Chia‐Lin Chou Taiwan	11	117 1.3×	47 0.6×	10 0.3×	65 1.8×	70 2.1×	39	311

Countries citing papers authored by S. Nitschmann

Since Specialization

Citations

This map shows the geographic impact of S. Nitschmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Nitschmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Nitschmann more than expected).

Fields of papers citing papers by S. Nitschmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Nitschmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Nitschmann. The network helps show where S. Nitschmann may publish in the future.

Co-authorship network of co-authors of S. Nitschmann

This figure shows the co-authorship network connecting the top 25 collaborators of S. Nitschmann. A scholar is included among the top collaborators of S. Nitschmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Nitschmann. S. Nitschmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Augustin, Max, Michael Hallek, & S. Nitschmann. (2022). Myokarditisrisiko bei mRNA-Impfstoffen zur Prävention von COVID-19. Der Internist. 63(4). 461–464.

Aringer, Martin & S. Nitschmann. (2022). Anifrolumab für die Therapie des systemischen Lupus erythematodes. Die Innere Medizin. 63(9). 1009–1012.

Augustin, Max, Michael Hallek, & S. Nitschmann. (2021). Antikörpertherapie bei Patienten mit COVID-19. Der Internist. 62(5). 572–576.

Windler, E. & S. Nitschmann. (2021). Evinacumab bei Patienten mit therapierefraktärer Hypercholesterinämie. Der Internist. 62(6). 686–689. 1 indexed citations

Scherbaum, Werner A. & S. Nitschmann. (2020). Starke Gewichtsreduktion durch Diät normalisiert Stoffwechsel bei Adipositas und Typ-2-Diabetes im gleichen Ausmaß wie Magenbypass. Der Internist. 61(12). 1308–1310.

Augustin, Max, Michael Hallek, & S. Nitschmann. (2020). Impfstoffentwicklung zur Prävention von COVID-19. Der Internist. 62(1). 106–110. 1 indexed citations

Gärtner, Roland & S. Nitschmann. (2020). Teprotumumab bei schilddrüsenassoziierter Ophthalmopathie. Der Internist. 61(11). 1208–1210.

Klingenberg, Roland & S. Nitschmann. (2020). Colchicintherapie nach Myokardinfarkt. Der Internist. 61(7). 766–769. 9 indexed citations

Augustin, Max, Michael Hallek, & S. Nitschmann. (2020). Remdesivir bei Patienten mit schwerer COVID-19. Der Internist. 61(6). 644–645. 10 indexed citations

10.

Augustin, Max, Michael Hallek, & S. Nitschmann. (2020). Remdesivir bei Patienten mit COVID-19. Der Internist. 61(8). 869–872. 2 indexed citations

11.

Nitschmann, S., et al.. (2020). Febuxostat oder Allopurinol bei Patienten mit Gicht. Der Internist. 61(5). 530–532. 4 indexed citations

12.

Nitschmann, S., et al.. (2020). Osteoarthritis des Knies: Physiotherapie oder intraartikuläre Kortikoidinjektionen. Der Internist. 61(10). 1087–1090. 2 indexed citations

13.

Moser, Martin & S. Nitschmann. (2018). Antikoagulative Strategie bei stabiler kardiovaskulärer Erkrankung. Der Internist. 59(6). 636–638. 2 indexed citations

14.

Gerken, Guido & S. Nitschmann. (2017). Obeticholsäure bei primär biliärer Cholangitis. Der Internist. 58(2). 202–204. 4 indexed citations

15.

Welte, Tobias & S. Nitschmann. (2016). Kardiovaskuläres Outcome bei Patienten mit COPD. Der Internist. 57(11). 1139–1141. 1 indexed citations

16.

Rasche, Kurt & S. Nitschmann. (2015). Ambulant erworbene Pneumonie. Der Internist. 56(12). 1458–1462. 1 indexed citations

17.

Vogelmeier, Claus & S. Nitschmann. (2011). Antibiotikatherapie bei akuter Exazerbation einer chronisch obstruktiven Lungenerkrankung. Der Internist. 52(6). 765–767.

18.

Rump, Lars Christian & S. Nitschmann. (2010). Medikamentöse vs. interventionelle Therapie der Nierenarterienstenose. Der Internist. 52(2). 218–220. 3 indexed citations

19.

Scherbaum, Werner A. & S. Nitschmann. (2010). Therapie der Adipositas mit Liraglutid. Der Internist. 51(8). 1064–1066. 2 indexed citations

20.

Kaufmann, Andreas M. & S. Nitschmann. (2010). Impfung gegen humane Papillomaviren. Der Internist. 51(3). 410–414. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact